# ChatGPT

---

### üß† MCQs (Multiple Choice Questions)

**1.** Which cytokine is produced by CD4‚Å∫ T cells and stimulates the maturation of B and T cells?  
A. IL-2  
B. IL-4  
C. IL-6  
D. IL-1

**2.** Interferon-alpha is primarily involved in:  
A. Anti-eosinophilic activity  
B. Antiviral activity  
C. B cell activation  
D. Platelet aggregation

**3.** Which cytokine is targeted by Infliximab?  
A. IL-1  
B. TNF-Œ±  
C. IL-6  
D. IL-23

**4.** Tocilizumab is used to inhibit which cytokine?  
A. IL-1  
B. IL-6  
C. IL-17  
D. IL-23

**5.** Which cytokine increases the antimicrobial activity of macrophages and regulates cytokine production by T cells?  
A. IFN-Œ±  
B. IL-6  
C. IFN-Œ≥  
D. IL-22

**6.** IL-5 is involved in the growth and differentiation of:  
A. Basophils and neutrophils  
B. B cells and eosinophils  
C. NK cells and B cells  
D. CD8‚Å∫ T cells and mast cells

**7.** IL-17 is mainly secreted by:  
A. CD8‚Å∫ T cells  
B. NK cells  
C. Th17 cells  
D. Macrophages

**8.** Which interleukin helps in plasma cell formation?  
A. IL-2  
B. IL-4  
C. IL-6  
D. IL-12

**9.** Which cytokine plays a role in stimulating neutrophil recruitment and fever?  
A. IL-23  
B. IL-1  
C. IL-2  
D. IL-4

**10.** Which cytokine is involved in activating NK cells and stimulating IFN-Œ≥ release?  
A. IL-4  
B. IL-12  
C. IL-23  
D. IL-5

**11.** Canakinumab targets which cytokine?  
A. IL-6  
B. IL-1  
C. IL-23  
D. IL-17

**12.** Which cytokine is produced by macrophages, NK cells, and T cells and is directly cytotoxic?  
A. IL-6  
B. TNF-Œ±  
C. IL-5  
D. IFN-Œ≥

**13.** IL-2 inhibitors are used in:  
A. Multiple sclerosis  
B. Transplant rejection  
C. Crohn's disease  
D. Asthma

**14.** Which interleukin is secreted by monocytes and macrophages and stimulates both neutrophils and B cells?  
A. IL-5  
B. IL-6  
C. IL-4  
D. IL-23

**15.** Which biologic targets IL-23?  
A. Ixekizumab  
B. Guselkumab  
C. Infliximab  
D. Tocilizumab

**16.** IL-22 plays a role in:  
A. Activating macrophages  
B. Epithelial cell proliferation  
C. CD8‚Å∫ T cell maturation  
D. IgE antibody production

**17.** IL-4 induces:  
A. TNF-Œ± expression  
B. IgG1 production  
C. IgE antibody production  
D. Interferon release

**18.** Which of the following cytokines are released from CD4‚Å∫ T cells and eosinophils?  
A. IL-4  
B. IL-2  
C. IL-5  
D. IL-6

**19.** Which biologic targets IL-17?  
A. Ustekinumab  
B. Tocilizumab  
C. Anakinra  
D. Infliximab

**20.** IL-23 is released by:  
A. CD4‚Å∫ T cells  
B. Activated macrophages and dendritic cells  
C. B cells  
D. Th1 cells

**21.** IL-6 inhibitors are used in:  
A. Type 1 diabetes  
B. Psoriasis  
C. Giant cell arteritis  
D. Ankylosing spondylitis

**22.** Which cytokine is important in chronic granulomatous disease treatment?  
A. IFN-Œ±  
B. IL-5  
C. IL-6  
D. IFN-Œ≥

**23.** Which cytokine is associated with eosinophilic vasculitis?  
A. IL-2  
B. IL-5  
C. IL-17  
D. IL-12

**24.** Which interleukin has synergy with IL-1 and TNF?  
A. IL-22  
B. IL-12  
C. IL-17  
D. IL-23

**25.** Which cytokine activates CD8‚Å∫ T cells?  
A. IFN-Œ≥  
B. IL-2  
C. IL-4  
D. IL-17

**26.** Interleukin responsible for producing fever and T cell activation in early inflammation:  
A. IL-1  
B. IL-12  
C. IL-22  
D. IL-6

**27.** Which cytokine is blocked by the biologic Anakinra?  
A. IL-6  
B. IL-1  
C. IL-12  
D. IL-17

**28.** Which cytokine is secreted by Th17 cells and induces epithelial protein production?  
A. IL-17  
B. IL-23  
C. IL-22  
D. IL-12

**29.** Which interleukin activates NK cells and stimulates IFN-Œ≥ production?  
A. IL-12  
B. IL-4  
C. IL-1  
D. IL-6

**30.** Which interleukin is produced by CD4‚Å∫ T cells and promotes antigen-specific proliferation?  
A. IL-4  
B. IL-2  
C. IL-12  
D. IL-17

**31.** Which cytokine is elevated in systemic juvenile arthritis?  
A. IL-23  
B. IL-5  
C. IL-1  
D. IL-17

**32.** Which cytokine has direct cytotoxic effects on cells?  
A. IL-4  
B. IFN-Œ±  
C. TNF-Œ±  
D. IL-2

**33.** IL-23 induces:  
A. CD8‚Å∫ T cell proliferation  
B. IgA production  
C. IL-17 secretion  
D. B cell maturation

**34.** Which cytokine is involved in psoriasis, psoriatic arthritis, and ankylosing spondylitis?  
A. IL-5  
B. IL-6  
C. IL-17  
D. IL-22

**35.** Which cytokine is known for pro-inflammatory actions and is blocked in rheumatoid arthritis therapy?  
A. IL-4  
B. TNF-Œ±  
C. IL-2  
D. IL-17

**36.** Which cytokine is produced by monocytes and macrophages and activates both T cells and neutrophils?  
A. IL-6  
B. IL-12  
C. IL-23  
D. IL-1

**37.** IL-2 is primarily secreted by:  
A. B cells  
B. CD8‚Å∫ T cells  
C. CD4‚Å∫ T cells  
D. NK cells

**38.** Ustekinumab targets:  
A. IL-1  
B. IL-6  
C. IL-12 and IL-23  
D. IFN-Œ≥

**39.** Which cytokine stimulates differentiation of B cells into plasma cells?  
A. IL-5  
B. IL-6  
C. IL-22  
D. IL-4

**40.** Which interleukin is involved in Th17 activation?  
A. IL-2  
B. IL-12  
C. IL-23  
D. IL-5

**41.** Ixekizumab blocks:  
A. IL-17  
B. IL-1  
C. IL-6  
D. IL-4

**42.** Which cytokine has been targeted using Mepolizumab?  
A. IL-5  
B. IL-4  
C. IL-6  
D. IL-17

**43.** Interferon-alpha activates which cells?  
A. B cells  
B. Mast cells  
C. NK and CD8‚Å∫ T cells  
D. Plasma cells

**44.** IL-1 inhibitors are used in:  
A. Asthma  
B. Rheumatoid arthritis and periodic fever syndromes  
C. Eosinophilic granulomatosis  
D. Atopic dermatitis

**45.** IL-6 increases expression of:  
A. TNF  
B. Eosinophils  
C. Adhesion molecules and neutrophils  
D. Plasma proteins

**46.** Which cytokine is involved in extracellular pathogen control and immunity?  
A. IL-4  
B. IL-12  
C. IL-17  
D. IL-5

**47.** Which cytokine is mainly involved in antiviral response?  
A. IL-17  
B. IL-1  
C. IFN-Œ±  
D. IL-22

**48.** Which interleukin is involved in IgE production?  
A. IL-2  
B. IL-4  
C. IL-1  
D. IL-22

**49.** Guselkumab targets:  
A. IL-6  
B. IL-17  
C. IL-23  
D. IL-1

**50.** Which interleukin is used therapeutically in hepatitis C?  
A. IL-2  
B. IL-6  
C. IFN-Œ±  
D. IL-23

---

### ‚úÖ Answers

1. B
    
2. B
    
3. B
    
4. B
    
5. C
    
6. B
    
7. C
    
8. C
    
9. B
    
10. B
    
11. B
    
12. B
    
13. B
    
14. B
    
15. B
    
16. B
    
17. C
    
18. C
    
19. A
    
20. B
    
21. C
    
22. D
    
23. B
    
24. C
    
25. B
    
26. A
    
27. B
    
28. C
    
29. A
    
30. B
    
31. C
    
32. C
    
33. C
    
34. C
    
35. B
    
36. B
    
37. C
    
38. C
    
39. B
    
40. C
    
41. A
    
42. A
    
43. C
    
44. B
    
45. C
    
46. C
    
47. C
    
48. B
    
49. C
    
50. C

# Grok
### Multiple Choice Questions

1. Which cytokine is primarily produced by T cells and macrophages and has anti-viral activity?
   a) Interferon-alpha (IFN-Œ±)
   b) Interferon-gamma (IFN-Œ≥)
   c) Tumour necrosis factor alpha (TNF-Œ±)
   d) Interleukin-1 (IL-1)

2. What is the main source of Interferon-gamma (IFN-Œ≥)?
   a) Macrophages
   b) T cells and NK cells
   c) Monocytes
   d) Th17 cells

3. Which activity is associated with Tumour necrosis factor alpha (TNF-Œ±)?
   a) Anti-inflammatory
   b) Pro-inflammatory
   c) Stimulates neutrophil recruitment
   d) Regulates cytokine production

4. What biologic therapy is used for rheumatoid arthritis involving TNF-Œ± inhibitors?
   a) Infliximab
   b) Tocilizumab
   c) Ustekinumab
   d) Canakinumab

5. Which cytokine is produced by macrophages and neutrophils and stimulates neutrophil recruitment?
   a) Interleukin-1 (IL-1)
   b) Interleukin-2 (IL-2)
   c) Interleukin-4 (IL-4)
   d) Interleukin-5 (IL-5)

6. What is a common use of IL-1 inhibitors?
   a) Chronic granulomatous disease
   b) Systemic juvenile rheumatoid arthritis
   c) Transplant rejection
   d) Asthma

7. Which cytokine is primarily produced by CD4+ T cells and promotes proliferation and differentiation?
   a) Interleukin-2 (IL-2)
   b) Interleukin-3 (IL-3)
   c) Interleukin-4 (IL-4)
   d) Interleukin-6 (IL-6)

8. What biologic therapy targets IL-2 in the treatment of transplant rejection?
   a) Anakinra
   b) Canakinumab
   c) IL-2 inhibitors
   d) Mepolizumab

9. Which cytokine stimulates maturation of B and T cells and production of IgE antibody?
   a) Interleukin-4 (IL-4)
   b) Interleukin-5 (IL-5)
   c) Interleukin-6 (IL-6)
   d) Interleukin-12 (IL-12)

10. What is a biologic therapy used for severe atopic dermatitis involving IL-4 receptor?
    a) Mepolizumab
    b) Tocilizumab
    c) Dupilumab
    d) Ustekinumab

11. Which cytokine is produced by CD4+ T cells, mast cells, and eosinophils and supports B cell growth?
    a) Interleukin-5 (IL-5)
    b) Interleukin-6 (IL-6)
    c) Interleukin-12 (IL-12)
    d) Interleukin-17 (IL-17)

12. What biologic therapy is used in asthma involving IL-5?
    a) Mepolizumab
    b) Tocilizumab
    c) Canakinumab
    d) Secukinumab

13. Which cytokine is produced by monocytes and macrophages and stimulates neutrophil recruitment?
    a) Interleukin-6 (IL-6)
    b) Interleukin-12 (IL-12)
    c) Interleukin-17 (IL-17)
    d) Interleukin-22 (IL-22)

14. What biologic therapy targets IL-6 receptor in rheumatoid arthritis?
    a) Tocilizumab
    b) Infliximab
    c) Ustekinumab
    d) Guselkumab

15. Which cytokine is produced by monocytes and macrophages and stimulates IFN-Œ≥ and TNF-Œ± release?
    a) Interleukin-12 (IL-12)
    b) Interleukin-17 (IL-17)
    c) Interleukin-22 (IL-22)
    d) Interleukin-23 (IL-23)

16. What biologic therapy is used for psoriasis involving IL-12?
    a) Ustekinumab
    b) Secukinumab
    c) Ixekizumab
    d) Guselkumab

17. Which cytokine is produced by Th17 cells and acts as a pro-inflammatory cytokine?
    a) Interleukin-17 (IL-17)
    b) Interleukin-22 (IL-22)
    c) Interleukin-23 (IL-23)
    d) Interferon-alpha (IFN-Œ±)

18. What biologic therapy is used for psoriasis involving IL-17?
    a) Secukinumab
    b) Tocilizumab
    c) Mepolizumab
    d) Canakinumab

19. Which cytokine is produced by Th17 cells and induces epidermal cell proliferation?
    a) Interleukin-22 (IL-22)
    b) Interleukin-23 (IL-23)
    c) Interleukin-4 (IL-4)
    d) Interleukin-6 (IL-6)

20. What biologic therapy targets IL-23 in psoriasis?
    a) Guselkumab
    b) Infliximab
    c) Dupilumab
    d) Anakinra

21. Which cytokine is produced by activated macrophages and dendritic cells in peripheral tissues?
    a) Interleukin-23 (IL-23)
    b) Interleukin-1 (IL-1)
    c) Interleukin-5 (IL-5)
    d) Interferon-gamma (IFN-Œ≥)

22. What is the primary action of Interleukin-23 (IL-23)?
    a) Anti-inflammatory
    b) Pro-inflammatory cytokine
    c) Stimulates neutrophil recruitment
    d) Regulates cytokine production

23. Which biologic therapy is used for hepatitis C involving IFN-Œ±?
    a) Recombinant IFN-Œ±
    b) Tocilizumab
    c) Secukinumab
    d) Mepolizumab

24. What is a key function of Interferon-gamma (IFN-Œ≥) in macrophages?
    a) Increases antimicrobial activity
    b) Inhibits cytokine production
    c) Promotes B cell growth
    d) Stimulates IgE production

25. Which cytokine inhibitor is used for chronic granulomatous disease?
    a) Interferon-Œ≥
    b) TNF-Œ± inhibitors
    c) IL-1 inhibitors
    d) IL-6 inhibitors

26. What is the source of Tumour necrosis factor alpha (TNF-Œ±)?
    a) T cells and NK cells
    b) Macrophages, NK cells, and T cells
    c) Monocytes and macrophages
    d) CD4+ T cells

27. Which biologic therapy is used for inflammatory bowel disease involving IL-23?
    a) Guselkumab
    b) Ustekinumab
    c) Infliximab
    d) Tocilizumab

28. What is the primary action of Interleukin-1 (IL-1) on the immune response?
    a) Increases antimicrobial activity
    b) Stimulates neutrophil recruitment
    c) Promotes T cell differentiation
    d) Inhibits macrophage response

29. Which cytokine is targeted by Canakinumab in the treatment of periodic fever syndromes?
    a) IL-1
    b) IL-2
    c) IL-6
    d) TNF-Œ±

30. What is a common use of Mepolizumab in treatment?
    a) Rheumatoid arthritis
    b) Asthma
    c) Psoriasis
    d) Transplant rejection

31. Which cytokine stimulates the maturation of B cells into plasma cells?
    a) Interleukin-6 (IL-6)
    b) Interleukin-4 (IL-4)
    c) Interleukin-12 (IL-12)
    d) Interleukin-17 (IL-17)

32. What biologic therapy targets p40 subunit of IL-12 used in psoriatic arthritis?
    a) Ustekinumab
    b) Secukinumab
    c) Ixekizumab
    d) Dupilumab

33. Which cytokine is involved in controlling extracellular pathogens and synergy with TNF?
    a) Interleukin-17 (IL-17)
    b) Interleukin-22 (IL-22)
    c) Interferon-alpha (IFN-Œ±)
    d) Interleukin-23 (IL-23)

34. What is a key action of Interleukin-5 (IL-5) on eosinophils?
    a) Growth and differentiation factor
    b) Inhibits IgE production
    c) Increases antimicrobial activity
    d) Promotes T cell proliferation

35. Which biologic therapy is used for giant cell arteritis involving IL-6?
    a) Tocilizumab
    b) Infliximab
    c) Canakinumab
    d) Ustekinumab

36. What is the primary source of Interleukin-12 (IL-12)?
    a) Th17 cells
    b) Monocytes and macrophages
    c) CD4+ T cells
    d) NK cells

37. Which cytokine inhibitor is used for ankylosing spondylitis involving IL-17?
    a) Secukinumab
    b) Mepolizumab
    c) Tocilizumab
    d) Anakinra

38. What is a common use of Guselkumab in treatment?
    a) Asthma
    b) Psoriatic arthritis
    c) Rheumatoid arthritis
    d) Chronic granulomatous disease

39. Which cytokine is involved in the induction of epithelial cell proliferation and antimicrobial proteins?
    a) Interleukin-22 (IL-22)
    b) Interleukin-23 (IL-23)
    c) Interferon-gamma (IFN-Œ≥)
    d) Interleukin-1 (IL-1)

40. What biologic therapy targets IL-23 in inflammatory bowel disease?
    a) Ustekinumab
    b) Infliximab
    c) Dupilumab
    d) Secukinumab

41. Which cytokine activates NK cells, CD8+ T cells, and macrophages?
    a) Interferon-alpha (IFN-Œ±)
    b) Interferon-gamma (IFN-Œ≥)
    c) Tumour necrosis factor alpha (TNF-Œ±)
    d) Interleukin-6 (IL-6)

42. What is a key function of Interleukin-4 (IL-4) in the immune response?
    a) Stimulates neutrophil recruitment
    b) Stimulates maturation of B and T cells
    c) Increases antimicrobial activity
    d) Promotes Th17 cell differentiation

43. Which biologic therapy is used for systemic juvenile rheumatoid arthritis?
    a) Anakinra
    b) Tocilizumab
    c) Mepolizumab
    d) Ustekinumab

44. What is the primary action of Interleukin-23 (IL-23) on Th17 cells?
    a) Inhibits proliferation
    b) Proliferation with induction of IL-17
    c) Stimulates IgE production
    d) Increases antimicrobial activity

45. Which cytokine is targeted by Ixekizumab in psoriasis?
    a) IL-17
    b) IL-23
    c) IL-6
    d) TNF-Œ±

46. What is a common use of Dupilumab in treatment?
    a) Psoriasis
    b) Severe atopic dermatitis
    c) Rheumatoid arthritis
    d) Transplant rejection

47. Which cytokine supports the growth of B cells and eosinophils?
    a) Interleukin-5 (IL-5)
    b) Interleukin-6 (IL-6)
    c) Interleukin-12 (IL-12)
    d) Interleukin-22 (IL-22)

48. What biologic therapy is used for hepatitis C involving IFN-Œ±?
    a) Recombinant IFN-Œ±
    b) Infliximab
    c) Secukinumab
    d) Tocilizumab

49. Which cytokine is involved in the control of mucosal immunity and synergy with TNF?
    a) Interleukin-17 (IL-17)
    b) Interleukin-22 (IL-22)
    c) Interferon-alpha (IFN-Œ±)
    d) Interleukin-23 (IL-23)

50. What is a key action of Tumour necrosis factor alpha (TNF-Œ±) on target cells?
    a) Causes apoptosis
    b) Inhibits neutrophil recruitment
    c) Promotes B cell maturation
    d) Increases antimicrobial activity

### Answers

1. a) Interferon-alpha (IFN-Œ±)
2. b) T cells and NK cells
3. b) Pro-inflammatory
4. a) Infliximab
5. a) Interleukin-1 (IL-1)
6. b) Systemic juvenile rheumatoid arthritis
7. a) Interleukin-2 (IL-2)
8. c) IL-2 inhibitors
9. a) Interleukin-4 (IL-4)
10. c) Dupilumab
11. a) Interleukin-5 (IL-5)
12. a) Mepolizumab
13. a) Interleukin-6 (IL-6)
14. a) Tocilizumab
15. a) Interleukin-12 (IL-12)
16. a) Ustekinumab
17. a) Interleukin-17 (IL-17)
18. a) Secukinumab
19. a) Interleukin-22 (IL-22)
20. a) Guselkumab
21. a) Interleukin-23 (IL-23)
22. b) Pro-inflammatory cytokine
23. a) Recombinant IFN-Œ±
24. a) Increases antimicrobial activity
25. a) Interferon-Œ≥
26. b) Macrophages, NK cells, and T cells
27. b) Ustekinumab
28. b) Stimulates neutrophil recruitment
29. a) IL-1
30. b) Asthma
31. a) Interleukin-6 (IL-6)
32. a) Ustekinumab
33. a) Interleukin-17 (IL-17)
34. a) Growth and differentiation factor
35. a) Tocilizumab
36. b) Monocytes and macrophages
37. a) Secukinumab
38. b) Psoriatic arthritis
39. a) Interleukin-22 (IL-22)
40. b) Ustekinumab
41. a) Interferon-alpha (IFN-Œ±)
42. b) Stimulates maturation of B and T cells
43. a) Anakinra
44. b) Proliferation with induction of IL-17
45. a) IL-17
46. b) Severe atopic dermatitis
47. a) Interleukin-5 (IL-5)
48. a) Recombinant IFN-Œ±
49. a) Interleukin-17 (IL-17)
50. a) Causes apoptosis